Mereo BioPharma (MREO) Shares Outstanding (2017 - 2026)

Mereo BioPharma (MREO) has reported Shares Outstanding (Entity) for 10 consecutive years, with $798.1 million the latest figure, recorded in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.39% year-over-year to $798.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $798.1 million (changed 0.39% YoY) and the FY2025 annual result came in at $795.7 million, up 2.57% from the prior year.
• Shares Outstanding (Entity) was little changed at $798.1 million in Q1 2026 per MREO's latest filing, from $795.7 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for MREO reached as high as $798.1 million in Q1 2026 and fell as low as $623.9 million in Q1 2023.
• A 5-year average of $743.7 million and a median of $773.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) dropped 10.27% — and 2024, when it rose 17.63%.
• Year by year, Shares Outstanding (Entity) stood at $707.5 million in 2022, then slipped by 6.79% to $659.5 million in 2023, then gained by 17.63% to $775.7 million in 2024, then grew by 2.57% to $795.7 million in 2025, then advanced by 0.3% to $798.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $798.1 million, $795.7 million, and $795.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.